Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-21
2006-03-21
Jones, Dwayne C. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S423000, C514S562000, C424S440000, C424S465000
Reexamination Certificate
active
07015232
ABSTRACT:
The present invention is directed to ACE inhibitor-containing compositions stabilized by the presence of magnesium oxide. Preferably, the ACE inhibitor, quinapril, is protected from certain forms of degradation when prepared in a pharmaceutical composition consisting essentially of magnesium oxide as the stabilizing agent. The presence of magnesium oxide also lends itself to favorable processing conditions during the manufacture of ACE inhibitor-containing compositions, especially processing by wet granulation.
REFERENCES:
patent: 3320029 (1967-05-01), Adams
patent: 4344949 (1982-08-01), Hoefle et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4425355 (1984-01-01), Hoefle et al.
patent: 4743450 (1988-05-01), Harris et al.
patent: 4793998 (1988-12-01), Murthy et al.
patent: 4830853 (1989-05-01), Murthy et al.
patent: 5603943 (1997-02-01), Yanagawa
patent: 5622985 (1997-04-01), Olukotun et al.
patent: 5780057 (1998-07-01), Conte et al.
patent: 6531486 (2003-03-01), Sherman
patent: 0 468 929 (1990-07-01), None
patent: 468929 (1992-01-01), None
patent: 526862 (1993-02-01), None
patent: 468929 (1994-09-01), None
Captopril, Entry 1817, The Merck Index, 12th Edition, p. 288-289 (1996).
Univasc Product Information Brochure posted @ http://www.schwarzusa.com (1998).
Rex N. brogden, et al., Moexipril—A review of its use in the management of essential hypertension, Adis Drug Eval., Drugs., Jun., 55(6): 848-860 (1998).
“Everything You Ever Wanted To Know About Magnesium Oxide”, Martin Marietta Magnesia Specialties posted @ http://magspecilaties.com/students.htm (2001).
Daniel Jane Ellen
Harris Michael Ray
Hokanson Gerard Clifford
Weiss Jay
Ashbrook Charles W.
Boudreaux William R.
Jones Dwayne C.
Warner-Lambert Company LLC
LandOfFree
Stabilization of quinapril using magnesium oxide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilization of quinapril using magnesium oxide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilization of quinapril using magnesium oxide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3560627